Presence of decoy cells for 6 months on urine cytology efficiently predicts BK virus nephropathy in renal transplant recipients

被引:6
|
作者
Sekito, Takanori [1 ]
Araki, Motoo [1 ]
Yoshinaga, Kasumi [1 ]
Maruyama, Yuki [1 ]
Sadahira, Takuya [1 ]
Nishimura, Shingo [1 ]
Wada, Koichiro [1 ]
Watanabe, Masami [1 ]
Watanabe, Toyohiko [1 ]
Tanabe, Katsuyuki [2 ]
Takeuchi, Hidemi [2 ]
Morinaga, Hiroshi
Kitagawa, Masashi [4 ]
Kitamura, Shinji [2 ]
Sugiyama, Hitoshi [3 ,5 ]
Wada, Jun [2 ]
Yanai, Hiroyuki [6 ]
Nasu, Yasutomo [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan
[3] Okayama Univ Hosp, Div Med Informat, Okayama, Japan
[4] Okayama Med Ctr, Dept Nephrol, Okayama, Japan
[5] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Department Human Resource Dev Dialysis Therapy Ki, Okayama, Japan
[6] Okayama Univ Hosp, Dept Pathol, Okayama, Japan
关键词
BK virus; cytology; kidney transplantation; polyomavirus infections; simian virus 40; POLYOMAVIRUS BK;
D O I
10.1111/iju.14679
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To investigate the association between duration of consecutive presence of decoy cells on urine cytology and BK virus nephropathy after kidney transplantation. Methods In total, 121 kidney transplant recipients were retrospectively evaluated. The best duration of consecutive presence of decoy cells that could be used to predict BK virus nephropathy was analyzed using the area under the curve for each duration, and recipients were divided into two groups based on the best predictive performance. The effectiveness of SV40 immunostaining on urinary cytology was also analyzed. Results In total, 2534 urine specimens as well as SV40 immunostaining in 2241 urine specimens were analyzed. Six consecutive months of decoy cell positivity had the best predictive performance for BK virus nephropathy (area under the curve = 0.832). The incidence of BK virus nephropathy in recipients with positive decoy cells for 6 months or more consecutive months (5/44) was significantly higher than in those who had positive decoy cells for less than 6 months (0/77; P = 0.005). Decoy cell positivity had a sensitivity, specificity, positive predictive value, and negative predictive value for BK virus nephropathy of 100%, 66%, 11%, and 100% respectively. SV40 immunostaining provided slightly better specificity (68%) and positive predictive value (12%). Conclusions The detection of decoy cells at 6 months or more on urine cytology had high predictive value for BK virus nephropathy in kidney transplant recipients. SV40 immunostaining on urine cytology added minimal diagnostic accuracy.
引用
收藏
页码:1240 / 1246
页数:7
相关论文
共 50 条
  • [21] Monitoring the progress of BK virus associated nephropathy in renal transplant recipients
    Tong, CYW
    Hilton, R
    MacMahon, EME
    Brown, L
    Pantelidis, P
    Chrystie, IL
    Kidd, IM
    Tungekar, MF
    Pattison, JM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (10) : 2598 - 2605
  • [22] Quantitation of BK Virus DNA for Diagnosis of BK Virus-Associated Nephropathy in Renal Transplant Recipients
    Sung, Heungsup
    Choi, Byung Hoo
    Pyo, Yeon Jung
    Kim, Mi-Na
    Han, Duck Jong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (05) : 814 - 818
  • [23] BK Virus Encoded MicroRNAs Are Present in Blood of Renal Transplant Recipients With BK Viral Nephropathy
    Li, J. Y. Z.
    McNicholas, K.
    Yong, T. Y.
    Rao, N.
    Coates, P. T. H.
    Higgins, G. D.
    Carroll, R. P.
    Woodman, R. J.
    Michael, M. Z.
    Gleadle, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (05) : 1183 - 1190
  • [24] HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients
    Awadalla, Y
    Randhawa, P
    Ruppert, K
    Zeevi, A
    Duquesnoy, RJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) : 1691 - 1696
  • [25] BK virus nephropathy management in pediatric renal transplant recipients: a series of cases
    Cardoso, R.
    Watanabe, A.
    Metran, C.
    Henriques, L.
    David, D.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1948 - 1949
  • [26] Periodic assessment of urine and serum by cytology and molecular biology as a diagnostic tool for BK Virus nephropathy in renal transplant patients
    Boldorini, R
    Brustia, M
    Veggiani, C
    Barco, D
    Andorno, S
    Monga, G
    ACTA CYTOLOGICA, 2005, 49 (03) : 235 - 243
  • [27] Ureteral stent placement and BK virus allograft nephropathy in renal transplant recipients
    Kazory, Amir
    Ducloux, Didier
    TRANSPLANTATION, 2008, 85 (04) : 657 - 658
  • [28] Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients
    Limaye, AP
    Jerome, KR
    Kuhr, CS
    Ferrenberg, J
    Huang, ML
    Davis, CL
    Corey, L
    Marsh, CL
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (11): : 1669 - 1672
  • [29] Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients
    Almeras, C.
    Vetromile, F.
    Garrigue, V.
    Szwarc, I.
    Foulongne, V.
    Mourad, G.
    TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (02) : 101 - 108
  • [30] Efficacy of Intravenous lmmunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients
    Vu, D.
    Shah, T.
    Ansari, J.
    Naraghi, R.
    Min, D.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (02) : 394 - 398